Acute Safety and Acceptability Study of Experimental Device RD19 for Protection From Human Respiratory Disease Pathogens
Condition:   Respiratory Tract Infections Intervention:   Device: RD19 Sponsors:   KNOWBio Inc.;   M3-Wake Research Associates;   Carolina Phase I;   TAB Clinical Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2020 Category: Research Source Type: clinical trials

Long-term Characterization of Patients With Severe/Critical Infection by COVID-19 Virus
Condition:   Covid19 Interventions:   Radiation: chest radiography;   Radiation: thoracic computed tomography scan;   Diagnostic Test: spirometry;   Diagnostic Test: Diffusing capacity of carbon monoxide;   Diagnostic Test: 6 minute walk test;   Diagnostic Test: saint george respiratory questionnaire Sponsor:   Fundacion Clinica Valle del Lili Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2020 Category: Research Source Type: clinical trials

Functional Recovery From Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19: Influence of Socio-Economic Status
Conditions:   Covid19;   ARDS;   Functional Recovery Interventions:   Other: Paraclinical examination;   Other: Clinical Examination;   Other: Semi-directive interview;   Other: quality of life questionnaires Sponsor:   Centre Hospitalier Universitaire Dijon Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2020 Category: Research Source Type: clinical trials

Functional Recovery From Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19: Influence of Socio-Economic Status
Conditions:   Covid19;   ARDS;   Functional Recovery Interventions:   Other: Paraclinical examination;   Other: Clinical Examination;   Other: Semi-directive interview;   Other: quality of life questionnaires Sponsor:   Centre Hospitalier Universitaire Dijon Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2020 Category: Research Source Type: clinical trials

The effect of physiotherapy including frequent changes of body position and stimulation to physical activity for infants hospitalised with acute airway infections. Study protocol for a randomised controlled trial
This study is a clinical two-centre individually randomised controlled trial (RCT) with three parallel groups. The participants will be randomly assigned to an individualised physiotherapy intervention, a non-individualised intervention, or a control group. All three groups will receive the standard care at the ward, and the two intervention groups will receive additional treatment, including different movements of the body. The primary outcome measure is a clinical index based on determinants for hospitalisation. Baseline assessments will be compared with the assessments after 24  h. The secondary outcome measures ...
Source: Trials - September 21, 2020 Category: Research Source Type: clinical trials

Functional Recovery From Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19: Influence of Socio-Economic Status
Conditions:   Covid19;   ARDS;   Functional Recovery Interventions:   Other: Paraclinical examination;   Other: Clinical Examination;   Other: Semi-directive interview;   Other: quality of life questionnaires Sponsor:   Centre Hospitalier Universitaire Dijon Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 20, 2020 Category: Research Source Type: clinical trials

New Treatment for COVID 19 Respiratory Tract by Controlled Ethanol Vapor Inhalation Combined With Asprin .
Conditions:   Covid19;   Drug Effect Intervention:   Drug: Ethanol with Asprin Sponsor:   Mansoura University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2020 Category: Research Source Type: clinical trials

Respiratory Dysfunction in Acute Pancreatitis (SAFI)
Conditions:   Acute Pancreatitis;   Complication Intervention:   Other: Non invasive oxygenation Sponsor:   Dr. med. Hector Eloy Tamez Perez Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 17, 2020 Category: Research Source Type: clinical trials

Epidemiologic, Clinical and Molecular Characteristics of Patients With Acute Respiratory Failure Affected by 2019-NCOV.
Condition:   Covid19 Intervention:   Other: Patient with SAR-CoV-2 infection Sponsor:   Istituto Clinico Humanitas Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 17, 2020 Category: Research Source Type: clinical trials

Study of Biomarkers in Patients of Sepsis Complicated With Acute Respiratory Distress Syndrome (ARDS)
Conditions:   Sepsis;   Acute Respiratory Distress Syndrome Intervention:   Sponsor:   Tianjin Nankai Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 17, 2020 Category: Research Source Type: clinical trials

Epidemiologic, Clinical and Molecular Characteristics of Patients With Acute Respiratory Failure Affected by 2019-NCOV.
Condition:   Covid19 Intervention:   Other: Patient with SAR-CoV-2 infection Sponsor:   Istituto Clinico Humanitas Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 17, 2020 Category: Research Source Type: clinical trials

Respiratory Dysfunction in Acute Pancreatitis (SAFI)
Conditions:   Acute Pancreatitis;   Complication Intervention:   Other: Non invasive oxygenation Sponsor:   Dr. med. Hector Eloy Tamez Perez Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 17, 2020 Category: Research Source Type: clinical trials

Study of Biomarkers in Patients of Sepsis Complicated With Acute Respiratory Distress Syndrome (ARDS)
Conditions:   Sepsis;   Acute Respiratory Distress Syndrome Intervention:   Sponsor:   Tianjin Nankai Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 17, 2020 Category: Research Source Type: clinical trials

Epidemiologic, Clinical and Molecular Characteristics of Patients With Acute Respiratory Failure Affected by 2019-NCOV.
Condition:   Covid19 Intervention:   Other: Patient with SAR-CoV-2 infection Sponsor:   Istituto Clinico Humanitas Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 17, 2020 Category: Research Source Type: clinical trials

Respiratory Dysfunction in Acute Pancreatitis (SAFI)
Conditions:   Acute Pancreatitis;   Complication Intervention:   Other: Non invasive oxygenation Sponsor:   Dr. med. Hector Eloy Tamez Perez Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 17, 2020 Category: Research Source Type: clinical trials

Epidemiologic, Clinical and Molecular Characteristics of Patients With Acute Respiratory Failure Affected by 2019-NCOV.
Condition:   Covid19 Intervention:   Other: Patient with SAR-CoV-2 infection Sponsor:   Istituto Clinico Humanitas Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 17, 2020 Category: Research Source Type: clinical trials

Study of Biomarkers in Patients of Sepsis Complicated With Acute Respiratory Distress Syndrome (ARDS)
Conditions:   Sepsis;   Acute Respiratory Distress Syndrome Intervention:   Sponsor:   Tianjin Nankai Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 17, 2020 Category: Research Source Type: clinical trials

Respiratory Dysfunction in Acute Pancreatitis (SAFI)
Conditions:   Acute Pancreatitis;   Complication Intervention:   Other: Non invasive oxygenation Sponsor:   Dr. med. Hector Eloy Tamez Perez Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 17, 2020 Category: Research Source Type: clinical trials

Epidemiologic, Clinical and Molecular Characteristics of Patients With Acute Respiratory Failure Affected by 2019-NCOV.
Condition:   Covid19 Intervention:   Other: Patient with SAR-CoV-2 infection Sponsor:   Istituto Clinico Humanitas Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 17, 2020 Category: Research Source Type: clinical trials

Study of Biomarkers in Patients of Sepsis Complicated With Acute Respiratory Distress Syndrome (ARDS)
Conditions:   Sepsis;   Acute Respiratory Distress Syndrome Intervention:   Sponsor:   Tianjin Nankai Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 17, 2020 Category: Research Source Type: clinical trials

Respiratory Dysfunction in Acute Pancreatitis (SAFI)
Conditions:   Acute Pancreatitis;   Complication Intervention:   Other: Non invasive oxygenation Sponsor:   Dr. med. Hector Eloy Tamez Perez Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 17, 2020 Category: Research Source Type: clinical trials

Epidemiologic, Clinical and Molecular Characteristics of Patients With Acute Respiratory Failure Affected by 2019-NCOV.
Condition:   Covid19 Intervention:   Other: Patient with SAR-CoV-2 infection Sponsor:   Istituto Clinico Humanitas Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 17, 2020 Category: Research Source Type: clinical trials

Study of Biomarkers in Patients of Sepsis Complicated With Acute Respiratory Distress Syndrome (ARDS)
Conditions:   Sepsis;   Acute Respiratory Distress Syndrome Intervention:   Sponsor:   Tianjin Nankai Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 17, 2020 Category: Research Source Type: clinical trials

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)
Condition:   Covid19 Interventions:   Drug: BGB-DXP593;   Drug: Placebo Sponsor:   BeiGene Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 16, 2020 Category: Research Source Type: clinical trials

Study to Evaluate the Safety and Efficacy of VIRAZOLE ® in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19
Condition:   COVID19 Interventions:   Drug: 50 mg/mL Virazole;   Drug: 100 mg/mL Virazole Sponsor:   Bausch Health Americas, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 16, 2020 Category: Research Source Type: clinical trials

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)
Condition:   Covid19 Interventions:   Drug: BGB-DXP593;   Drug: Placebo Sponsor:   BeiGene Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 16, 2020 Category: Research Source Type: clinical trials

Study to Evaluate the Safety and Efficacy of VIRAZOLE ® in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19
Condition:   COVID19 Interventions:   Drug: 50 mg/mL Virazole;   Drug: 100 mg/mL Virazole Sponsor:   Bausch Health Americas, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 16, 2020 Category: Research Source Type: clinical trials

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)
Condition:   Covid19 Interventions:   Drug: BGB-DXP593;   Drug: Placebo Sponsor:   BeiGene Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 16, 2020 Category: Research Source Type: clinical trials

Study to Evaluate the Safety and Efficacy of VIRAZOLE ® in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19
Condition:   COVID19 Interventions:   Drug: 50 mg/mL Virazole;   Drug: 100 mg/mL Virazole Sponsor:   Bausch Health Americas, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 16, 2020 Category: Research Source Type: clinical trials

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)
Condition:   Covid19 Interventions:   Drug: BGB-DXP593;   Drug: Placebo Sponsor:   BeiGene Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 16, 2020 Category: Research Source Type: clinical trials

Study to Evaluate the Safety and Efficacy of VIRAZOLE ® in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19
Condition:   COVID19 Interventions:   Drug: 50 mg/mL Virazole;   Drug: 100 mg/mL Virazole Sponsor:   Bausch Health Americas, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 16, 2020 Category: Research Source Type: clinical trials

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)
Condition:   Covid19 Interventions:   Drug: BGB-DXP593;   Drug: Placebo Sponsor:   BeiGene Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 16, 2020 Category: Research Source Type: clinical trials

Study to Evaluate the Safety and Efficacy of VIRAZOLE ® in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19
Condition:   COVID19 Interventions:   Drug: 50 mg/mL Virazole;   Drug: 100 mg/mL Virazole Sponsor:   Bausch Health Americas, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 16, 2020 Category: Research Source Type: clinical trials

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)
Condition:   Covid19 Interventions:   Drug: BGB-DXP593;   Drug: Placebo Sponsor:   BeiGene Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 16, 2020 Category: Research Source Type: clinical trials

Study to Evaluate the Safety and Efficacy of VIRAZOLE ® in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19
Condition:   COVID19 Interventions:   Drug: 50 mg/mL Virazole;   Drug: 100 mg/mL Virazole Sponsor:   Bausch Health Americas, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 16, 2020 Category: Research Source Type: clinical trials

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)
Condition:   Covid19 Interventions:   Drug: BGB-DXP593;   Drug: Placebo Sponsor:   BeiGene Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 16, 2020 Category: Research Source Type: clinical trials

Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial
This study will also provide supportive evidence to that provided by currently ongoing studies on the efficacy and safety of sarilumab in this clinical context.Trial designA phase two multi-center randomised controlled trial (RCT) with two parallel arms (1:1 ratio).ParticipantsThey will be hospitalized patients, of at least 18 years of age, with severe COVID-19 who have positive RT-PCR test and have radiographic evidence of pulmonary infiltrates by imaging or rales/crackles on exam and SpO2 ≤ 94% on room air that requires supplemental oxygen. Patients must present elevation of inflammatory parameters (IL-6> 40 pg/mL ...
Source: Trials - September 16, 2020 Category: Research Source Type: clinical trials

COVID-19 Related Lung Ventilation and Perfusion Injury
Conditions:   Covid-19;   Asthma;   Healthy Interventions:   Other: V/Q SPECT-CT;   Other: St. George's Respiratory Questionnaire (SGRQ);   Other: mMRC (Modified Medical Research Council) Dyspnea Scale;   Other: Six-minute walk test (6MWT);   Other: Spirometry;   Other: Plethysmography & DLCO;   Other: Airwave Oscillometry Sponsors:   McMaster University;   Research St. Joseph's - Hamilton;   Cyclomedica Australia Pty Ltd Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 15, 2020 Category: Research Source Type: clinical trials

EFFECT of WHOLE BODY VIBRATION on FUNCTIONAL CAPACITY and RESPIRATORY FUNCTIONS IN STROKE INDIVIDUALS
Conditions:   Stroke;   Respiratory Function Impaired Intervention:   Other: rehabilitation Sponsor:   Suleyman Demirel University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 14, 2020 Category: Research Source Type: clinical trials